Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (10143)	7/10/2007 8:19:10 AM
From: kenhott	of 10280

Xyzal... I would think 10% is a pretty good guess. Sanofi is selling it in the USA. My guess is $300m sales in the US. Looks like they may try a evening time dosing idea to avoid the sleepy issue. I think people don't realize, for instance, Clarinex is like a $700m WW drug. You didn't mention SEPR trying to buy KOSP (ya right) or the continue mouth movements about in-licensing. I guess one day it will happen... maybe before I croak.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next